Medipet Dog Fresh Breath Foaming Mousse 150ml

£9.9
FREE Shipping

Medipet Dog Fresh Breath Foaming Mousse 150ml

Medipet Dog Fresh Breath Foaming Mousse 150ml

RRP: £99
Price: £9.9
£9.9 FREE Shipping

In stock

We accept the following payment methods

Description

The company locate in Samutprakarn on the area of 8,000 square meters. Today we have more than 70 employees and two strong salesman teams, which cover all the area in Thailand. Today we reach our sale value to 300 millions baht per year of pet product. We have almost 800 pet shops customer in Thailand such as Manoon Pet Shop, KU Garden, The Mall Group, Max Value, Pet Safari and etc. Sudden and progressive deterioration in asthma control is potentially life-threatening and consideration should be given to increasing corticosteroid dosage. In patients considered at risk, daily peak flow monitoring may be instituted. Adults and children over 16 years: 100 to 1,000 micrograms twice daily, usually as two twice daily inhalations.

For patients with mild asthma, a typical starting dose is 100 micrograms twice daily. In moderate and more severe asthma, starting doses may need to be 250 to 500 micrograms twice daily. Where additional clinical benefit is expected, doses of up to 1000 micrograms twice daily may be used. Initiation of such doses should be prescribed only by a specialist in the management of asthma (such as a consultant physician or general practitioner with appropriate experience). Replacement of systemic steroid treatment with inhaled therapy sometimes unmasks allergies such as allergic rhinitis or eczema previously controlled by the systemic drug. These allergies should be symptomatically treated with antihistamine and/or topical preparations, including topical steroids. There are limited data in pregnant women. Administration of fluticasone propionate during pregnancy should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus. It is important, that the dose of inhaled corticosteroid is titrated to the lowest dose at which effective control is maintained. Treatment with fluticasone propionate should not be stopped abruptly.Hoarseness and candidiasis of the mouth and throat (thrush) occurs in some patients. Such patients may find it helpful to rinse out their mouth with water after using the inhaler. Symptomatic candidiasis can be treated with topical anti-fungal therapy whilst still continuing with Flixotide Evohaler. Not all pet insurance is the same – there are many different types of policy available, and the level of cover they provide varies. We welcome all breeds, & cover common-breed conditions as well as hereditary & congenital conditions that others don’t, without additional waiting periods

As with other inhalation therapy, paradoxical bronchospasm may occur (see section 4.4). This should be treated immediately with a fast-acting inhaled bronchodilator. Flixotide Evohaler should be discontinued immediately, the patient assessed, and if necessary alternative therapy instituted. There are no data on human fertility. Animal studies indicate no effects of fluticasone propionate on male or female fertility. Our Benefit Booster add-on assists with cover for conditions not covered in your plan (e.g. pre-existing conditions), & adds or increases benefits. This add-on is particularly beneficial for those expensive surgeries you cannot afford to pay for upfront Ongoing add-on cover for pets that develop chronic medical conditions lasting more than 3 months every year

Maximum benefit: this provides cover up to a maximum amount of money per condition. Once this limit is reached the condition is excluded Time-limited: provides cover for a set amount of time (usually 12 months). After this period the condition is excluded It is recommended that the height of children receiving prolonged treatment with inhaled corticosteroids is regularly monitored. If growth is slowed, therapy should be reviewed with the aim of reducing the dose of inhaled corticosteroid, if possible, to the lowest dose at which effective control of asthma is maintained. In addition, consideration should be given to referring the patient to a paediatric respiratory specialist. pet stroller and etc. We have our research team to expand and upgrade our product by searching new product and our customer needed. We are not just distribute our house brand, we also looking for other partner to distributed their product. We have been distributed many other item under their brand, and become a vital partner. We distributed under the brand "Cuddles",

The type of policy you choose will largely dictate the veterinary care your pet is able to receive, as well as the costs you’ll face, so it’s important to choose the right option for you.There was an increased reporting of pneumonia in studies of patients with COPD receiving FLIXOTIDE 500 micrograms. Physicians should remain vigilant for the possible development of pneumonia in patients with COPD as the clinical features of pneumonia and exacerbation frequently overlap. Acute: Inhalation of the drug in doses in excess of those recommended may lead to temporary suppression of adrenal function. This does not necessitate emergency action being taken. In these patients treatment with fluticasone propionate by inhalation should be continued at a dose sufficient to control asthma adrenal function recovers in a few days and can be verified by measuring plasma cortisol. The management of asthma should follow a stepwise programme, and patient response should be monitored clinically and by lung function tests. The excretion of fluticasone propionate into human breast milk has not been investigated. When measurable plasma levels were obtained in lactating laboratory rats following subcutaneous administration there was evidence of fluticasone propionate in the breast milk. However, plasma levels in patients following inhaled application of fluticasone propionate at recommended doses are likely to be low. As with other inhalation therapy, paradoxical bronchospasm may occur with an immediate increase in wheezing after dosing. Flixotide Evohaler should be discontinued immediately, the patient assessed and alternative therapy instituted if necessary.



  • Fruugo ID: 258392218-563234582
  • EAN: 764486781913
  • Sold by: Fruugo

Delivery & Returns

Fruugo

Address: UK
All products: Visit Fruugo Shop